Observational studyJournal of the American Heart Association2016

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.

Xiaoxi Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.